BetterLife Pharma Inc.
BETRF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $16,009 | $8,222 | $12,794 | $15,610 |
| - Cash | $8 | $37 | $8 | $174 |
| + Debt | $1,302 | $1,469 | $1,187 | $1,396 |
| Enterprise Value | $17,303 | $9,653 | $13,973 | $16,832 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$18 | -$18 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$3,191 | -$9,245 | -$11,916 |
| % Margin | – | – | – | – |
| Net Income | -$3,520 | -$2,889 | -$9,016 | -$12,159 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.028 | -0.026 | -0.1 | -0.16 |
| % Growth | -7.6% | 73.6% | 37.5% | – |
| Operating Cash Flow | -$2,022 | -$2,472 | -$1,504 | -$11,203 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,022 | -$2,472 | -$1,504 | -$11,203 |